TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 116 resultados LastUpdate Última actualización 05/02/2023 [10:08:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 5 nextPage   por página


Analyte sensors and sensing methods featuring dual detection of glucose and ketones

NºPublicación: AU2022283734A1 02/02/2023

Solicitante:

ABBOTT DIABETES CARE INC

JP_2022516279_A

Resumen de: AU2022283734A1

Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.

traducir

SYSTEMS AND METHODS FOR PROCESSING CONTINUOUS GLUCOSE MONITOR VALUES IN AUTOMATED INSULIN DELIVERY

NºPublicación: US2023034408A1 02/02/2023

Solicitante:

TANDEM DIABETES CARE INC [US]

Resumen de: US2023034408A1

Disclosed herein are systems and methods incorporating an ambulatory infusion pump and a CGM. These systems that can include software and related methods to provide improved automated insulin delivery algorithms that combine and/or filter CGM readings. Embodiments disclosed herein can combine and/or filter additional CGM readings received between therapy calculations by the algorithm to provide improved and more accurate insulin delivery. Methods can include filtering and/or combining CGM readings for a current dosing interval and/or or for past dosing intervals that are used to generate a predicted future glucose level to inform dosing.

traducir

Network Topology For Insulin Pump Systems

NºPublicación: AU2022291455A1 02/02/2023

Solicitante:

BIGFOOT BIOMEDICAL INC

US_2021110907_A1

Resumen de: AU2022291455A1

In one implementation, an insulin delivery system using an on-body network includes an insulin delivery device that is adapted to administer dosages of insulin to a patient; a controller that is adapted to control operation of the insulin delivery device, to establish a first network connection in which the controller acts in a central role, and to establish a second network connection in which the controller acts in a peripheral role; one or more peripheral devices that are adapted to generate patient data related to blood glucose levels and to transmit the patient data wirelessly over the first network connection, the peripheral devices acting in a peripheral role over the first network connection; and a mobile application installed on a mobile computing device that is programmed to communicate with the controller over the second network connection, the mobile application communicating in a central role over the second network connection. (FIG. 1) Cc-'

traducir

Body attachment unit for continuous blood glucose measurement

NºPublicación: AU2022291526A1 02/02/2023

Solicitante:

I SENS INC

JP_2022500127_A

Resumen de: AU2022291526A1

The present disclosure relates to a body attachment unit for continuous blood glucose measurement, in which the body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without performing additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start point in time can be adjusted to an appropriate point in time according to the user's needs, and activation occurs in a stabilized state, thereby providing the body attachment unit allowing more accurate blood glucose measurement.

traducir

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

NºPublicación: AU2022291499A1 02/02/2023

Solicitante:

ABBOTT DIABETES CARE INC

AU_2022200642_A1

Resumen de: AU2022291499A1

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose and glucose variability.

traducir

Glycemic urgency assessment and alerts interface

NºPublicación: AU2022287585A1 02/02/2023

Solicitante:

DEXCOM INC

JP_2022079506_A

Resumen de: AU2022287585A1

Systems and methods are disclosed that employ several or numerous factors in the determination of a glycemic urgency index (GUI), which may be based on a measured blood glucose level as well as other factors. The other factors may include time derivatives of the glucose level and/or other factors, e.g., user - entered data, data measured by other sensors or received from a network source, or historical data. The GUI is then presented to the user in an interesting way, e.g., via a background color or other inconspicuous notifier, e.g., on a mobile device such as a smart phone. The GUI may also be employed in the triggering of actionable alerts and alarms on an electronic device for the user. The GUI, or another index calculated from combinations of the variables and parameters described, may further be employed to drive a medicament delivery device such as a pump.

traducir

System and method for wireless communication of glucose data

NºPublicación: AU2022279518A1 02/02/2023

Solicitante:

DEXCOM INC

CN_114666771_PA

Resumen de: AU2022279518A1

Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection. The method also includes, during the second interval, the analyte sensor system transmitting the encrypted analyte value to the display device, if the determination indicates that the authentication was performed during the first interval.

traducir

Applicator for continuous blood glucose measurement device

NºPublicación: AU2022287557A1 02/02/2023

Solicitante:

I SENS INC

JP_2022529292_A

Resumen de: AU2022287557A1

The present disclosure relates to a continuous blood glucose measurement device and an applicator, wherein the continuous blood glucose measurement device is produced in a state in which a body attachment unit has been assembled inside an applicator, so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body only by simply activating the applicator. Particularly, the present invention provides a continuous blood glucose measurement device and an applicator, wherein the continuous blood glucose measurement device: includes a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use thereof, without additional work for connecting a separate transmitter, and easier maintenance; and is activated by a user's operation after the body attachment unit is attached to the body, so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.

traducir

Compositions and methods for reprogramming skin tissue to have insulinogenic and delivery functions

NºPublicación: AU2021301190A1 02/02/2023

Solicitante:

THE TRUSTEES OF INDIANA UNIV

BR_112022026798_PA

Resumen de: AU2021301190A1

Disclosed herein are compositions and

traducir

ADJUSTING INSULIN THERAPY SETTING BASED ON VARIABILITY OF BLOOD GLUCOSE VALUES

NºPublicación: US2023037068A1 02/02/2023

Solicitante:

BIGFOOT BIOMEICAL INC [US]

WO_2021072437_A1

Resumen de: US2023037068A1

A method of adjusting insulin therapy settings for a person with diabetes that treats the diabetes by administering first and second types of insulin includes: storing, in a non-transitory storage medium of an electronic device, a first-type insulin dosage suggestion for a person with diabetes regarding a first type of insulin having an active time that is longer than an active time for a second type of insulin; receiving blood glucose data for the person with diabetes, the blood glucose data including blood glucose values for a plurality of days; determining a first variability of the blood glucose values for a selected first period of time during the plurality of days; and modifying the first-type insulin dosage suggestion in the non-transitory storage medium based on the determined first variability.

traducir

INTEGRATED CLOSED-LOOP ARTIFICIAL PANCREAS AND DATA OBTAINING METHOD FOR PROGRAM MODULE THEREOF

NºPublicación: US2023029902A1 02/02/2023

Solicitante:

MEDTRUM TECH INC [CN]

US_2022347380_PA

Resumen de: US2023029902A1

An integrated closed-loop artificial pancreas includes: a detection module; a program module which is imported into the total daily dose algorithm and the current insulin infusion algorithm; and an infusion module which is connected to the program module. The infusion module includes an infusion tube which is used as the insulin infusion channel, the detecting electrodes are provided on/in the wall of the infusion tube, and the infusion module can infuse insulin required according to the data of the current insulin infusion dose. It takes only one insertion to perform both glucose detection and insulin infusion.

traducir

CLOSED-LOOP ARTIFICIAL PANCREAS CONTROLLED BY BODY MOVEMENTS

NºPublicación: US2023033130A1 02/02/2023

Solicitante:

MEDTRUM TECH INC [CN]

WO_2022116601_A1

Resumen de: US2023033130A1

A closed-loop artificial pancreas controlled by body movements, which includes: a sensor used for detecting blood glucose concentration; an infusion module used for infusing drug into the body; a control module connected to the sensor and the infusion module, respectively; and a sensing module operatively connected to the control module and used to sense or recognize the user's body movements, and different body movements represent different functional instructions, and according to the body movement sensed or recognized by the sensing module, the control module controls the sensor or the infusion module to execute corresponding functional instructions, which enhances the user experience.

traducir

DEVICE FOR DELIVERING MEDICATION INCLUDING INTERPOSER

NºPublicación: US2023031763A1 02/02/2023

Solicitante:

AITA BIO INC [US]

WO_2021119095_A1

Resumen de: US2023031763A1

A device is disclosed that is configured as a fully autonomous and integrated wearable apparatus for diabetes management. The device comprises a reservoir for storing the medication for subsequent delivery to a patient, a needle for delivering the medication to the patient subcutaneously, a micropump for pumping the medication from the reservoir through the needle for delivering the medication to the patient, control circuitry controlling operations of the micropump, an interposer configured as an adapter for (1) mounting the reservoir, micropump, the control circuitry and the needle, and (2) distributing medication through one or more channels within the interposer from the reservoir to the needle via the micropump and electrical signals between the control circuitry and micropump.

traducir

Treatment of Type 1 Diabetes

NºPublicación: US2023030204A1 02/02/2023

Solicitante:

GALVANI BIOELECTRONICS LTD [GB]
CENTRE NATIONALE DE LA RECHERCHE SCIENT [FR]
UNIV COTE DAZUR [FR]

US_2021339025_A1

Resumen de: US2023030204A1

Modulation of neural signaling of a pancreas-related sympathetic nerve is capable of improving glycaemic control by inhibiting T cell activation or migration to the pancreas, and hence providing a way of treating or preventing type 1 diabetes.

traducir

SYSTEM AND METHODS FOR DETERMINING HEALTH-RELATED METRICS FROM COLLECTED PHYSIOLOGICAL DATA

NºPublicación: US2023036114A1 02/02/2023

Solicitante:

MEASURE LABS INC [US]

US_2023034071_PA

Resumen de: US2023036114A1

Techniques and systems include predicting various health conditions using a photoplethysmography (PPG) signal or a video signal based on images of a patient's fingertip or other body portion captured using a mobile device. The video signal may be transformed into a pseudo PPG signal to measure blood volume changes in the patient's blood flow to derive data indicating a disease state or health-related characteristic, such as blood oxygen level, blood glucose level, heart rate variability, hemoglobin, respiration rate, or arrhythmia. Techniques involve real-time environment assessment and problematic issue detection, training an artificial intelligence (AI) model to measure signal quality so as to select high-quality signals from a range of signals, and domain adaption and transfer learning to make use of publicly available datasets.

traducir

IMPROVED PERSONAL HEALTH DATA COLLECTION

NºPublicación: US2023034358A1 02/02/2023

Solicitante:

LEMAN MICRO DEVICES SA [CH]

CN_115135236_PA

Resumen de: US2023034358A1

The invention disclosed herein relates to improvements in the collection personal health data. It further relates to a Personal Health Monitor (PHM), which may be a Personal Hand Held Monitor (PHHM), that incorporates a Signal Acquisition Device (SAD) and a processor with its attendant screen and other peripherals. The SAD is adapted to acquire signals which can be used to derive one or more measurements of parameters related to the health of a user. The computing and other facilities of the PHM with which the SAD is integrated are adapted to control and analyse signals received from the SAD. The personal health data collected by the SAD may include data related to one or more of blood pressure, pulse rate, blood oxygen level (SpO2), body temperature, respiration rate, ECG, cardiac output, heart function timing, arterial stiffness, tissue stiffness, hydration, blood viscosity, blood pressure variability, the concentration of constituents of the blood such as glucose or alcohol and the identity of the user.

traducir

METHODS FOR MONITORING INFUSION SITES FOR AMBULATORY INFUSION PUMPS

NºPublicación: US2023034283A1 02/02/2023

Solicitante:

TANDEM DIABETES CARE INC [US]

US_2020261649_A1

Resumen de: US2023034283A1

Disclosed herein are apparatuses and methods for improved use of infusion sites for infusion pumps. Apparatuses and methods for delivery of medicaments such as insulin disclosed herein can increase the effectiveness of therapy by more accurately determining when an infusion site is no longer absorbing insulin at an acceptable rate as well as determining the effectiveness of different infusion sites on the body with respect to each other and over time.

traducir

SYSTEM AND METHODS FOR DETERMINING HEALTH-RELATED METRICS FROM DATA COLLECTED BY A MOBILE DEVICE

NºPublicación: US2023034071A1 02/02/2023

Solicitante:

MEASURE LABS INC [US]

US_2023036114_PA

Resumen de: US2023034071A1

Techniques and systems include predicting various health conditions using a photoplethysmography (PPG) signal or a video signal based on images of a patient's fingertip or other tissue or other body portion captured using a mobile device, such as a smartphone or tablet. The video signal may be transformed into a pseudo PPG signal to measure blood volume changes in the patient's blood flow to derive data indicating a disease state or health-related characteristic, such as blood oxygen level, blood glucose level, heart rate variability, hemoglobin, respiration rate, or arrhythmia. Techniques involve real-time environment assessment and problematic issue detection, training an artificial intelligence (AI) model to measure signal quality so as to select high-quality signals from a range of signals, and domain adaption and transfer learning to make use of publicly available datasets.

traducir

SYSTEM AND METHODS FOR DETERMINING HEALTH-RELATED METRICS FROM COLLECTED PHYSIOLOGICAL DATA

NºPublicación: US2023032332A1 02/02/2023

Solicitante:

MEASURE LABS INC [US]

US_2023036114_PA

Resumen de: US2023032332A1

Techniques and systems include predicting various health conditions using a photoplethysmography (PPG) signal or a video signal based on images of a patient's fingertip or other body portion captured using a mobile device. The video signal may be transformed into a pseudo PPG signal to measure blood volume changes in the patient's blood flow to derive data indicating a disease state or health-related characteristic, such as blood oxygen level, blood glucose level, heart rate variability, hemoglobin, respiration rate, or arrhythmia. Techniques involve real-time environment assessment and problematic issue detection, training an artificial intelligence (AI) model to measure signal quality so as to select high-quality signals from a range of signals, and domain adaption and transfer learning to make use of publicly available datasets.

traducir

TUNABLE HYBRID III-V/IV LASER SENSOR SYSTEM-ON-A CHIP FOR REAL-TIME MONITORING OF A BLOOD CONSTITUENT CONCENTRATION LEVEL

NºPublicación: US2023036048A1 02/02/2023

Solicitante:

BROLIS SENSOR TECH UAB [LT]
UNIV GENT [BE]
IMEC VZW [BE]

US_2021353183_A1

Resumen de: US2023036048A1

A spectroscopic laser sensor based on hybrid III-V/IV system-on-a-chip technology. The laser sensor is configured to either (i) be used with a fiber-optic probe connected to an intravenous/intra-arterial optical catheter for direct invasive blood analyte concentration level measurement or (ii) be used to measure blood analyte concentration level non-invasively through an optical interface attached, e.g., to the skin or fingernail bed of a human. The sensor includes a III-V gain-chip, e.g., an AIGalnAsSb/GaSb based gain-chip, and a photonic integrated circuit, with laser wavelength filtering, laser wavelength tuning, laser wavelength monitoring, laser signal monitoring and signal output sections realized on a chip by combining IV-based semiconductor substrates and flip-chip AIGal-nAsSb/GaSb based photodetectors and embedded electronics for signal processing. Embodiments of the invention may be applied for real-time monitoring of critical blood analyte concentration levels such as lactates, urea, glucose, ammonia, albumin, etc.

traducir

Method for calibrating blood glucose value in continuous blood glucose measurement system

NºPublicación: AU2022291652A1 02/02/2023

Solicitante:

I SENS INC

KR_20220130646_PA

Resumen de: AU2022291652A1

The present disclosure relates to a method for calibrating a blood glucose value in a continuous blood glucose measurement system. More particularly, blood glucose values can be accurately calibrated according to a calibration mode by differently selecting calibration modes for calibrating blood glucose values on the basis of whether the difference between a blood glucose value measured by a continuous blood glucose measurement system and a reference blood glucose value measured by a separate blood glucose meter is outside a set range. In addition, the blood glucose value of a user can be accurately calibrated by activating, to be scrolled on an input window, only the ranges of the blood glucose value and a reference blood glucose value calculated on the basis of a preset critical range, or by forcibly or automatically calibrating the blood glucose value by a second calibration mode which uses multiple reference blood glucose values, when a reference blood glucose value outside the reference blood glucose value range is input.

traducir

SYSTEMS AND METHODS FOR TECHNICAL SUPPORT OF CONTINUOUS ANALYTE MONITORING AND SENSOR SYSTEMS

NºPublicación: US2023027200A1 26/01/2023

Solicitante:

DEXCOM INC [US]

US_2021398662_A1

Resumen de: US2023027200A1

Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.

traducir

TRANSPORT ELEMENT FOR TRANSPORTING A SUBSTANCE CONTAINED IN A RESERVOIR, INFUSION SET AND GLUCOSE REGULATING SYSTEM COMPRISING THE FORMER AND METHOD OF CONNECTING SUCH A TRANSPORT ELEMENT TO A RESERVOIR

NºPublicación: WO2023001789A1 26/01/2023

Solicitante:

INREDA DIABETIC B V [NL]

Resumen de: WO2023001789A1

The invention relates to a transport element for transporting a substance contained in a reservoir comprising a transport means, such as a conduit, tube, hose or the like, and a connector arranged at an inlet end of the transport means for connecting to said reservoir such that in a connected condition in which the connector is connected to said reservoir a medium through flow connection is provided between said reservoir and the inlet end of the transport means for receiving said substance from said reservoir, wherein the connector comprises aligning and holding means for aligning and holding the reservoir in a predetermined orientation with respect to and/or position along a longitudinal axis of the connector. The invention also relates to an infusion set, system or combination comprising such transport element, and to a method of at least fluidly connecting such a transport element to a reservoir.

traducir

SYSTEMS AND APPARATUSES FOR PROTECTING CONTINUOUS GLUCOSE MONITORING AND INSULIN INFUSION DEVICES

NºPublicación: US2023026387A1 26/01/2023

Solicitante:

FREEDOM BAND LLC [US]

WO_2023003673_PA

Resumen de: US2023026387A1

Systems and apparatuses for securing and protecting diabetes management devices, such as continuous glucose monitoring (CGM) devices and insulin infusion sets. An apparatus comprises a base having multiple pairs of arms which can be attached to a band. The apparatus also comprises a shell for retaining a diabetes management device and which may be unitarily formed with, or removably attached to, the base. A system may include an apparatus, a diabetes management device retained in the shell of the apparatus, and a band attached to the base of the apparatus. The band may be placed around a body part of a user, such as an arm or the abdomen. A system can include an adhesive patch which can adhere to the shell of an apparatus and which has an adhesive layer overlaid with multiple liners having cutlines formed therebetween.

traducir

Silicone Hydrogel Based Fluorescent Assay and Contact Lens

Nº publicación: US2023025694A1 26/01/2023

Solicitante:

UNIV MARYLAND [US]

Resumen de: US2023025694A1

A material, article, system and method include a probe composition that includes a hydrophobic portion, a hydrophilic portion, an analyte-binding portion and a fluorophore portion. The analyte-binding portion is configured to bind to an analyte in an aqueous solution. The fluorophore portion is configured to change an optical property of fluorescent light emitted in response to incident excitation light when the probe composition changes between a first state in which the analyte is not bound to the analyte-binding portion and a second state in which the analyte binds to the analyte-binding portion. A material includes the probe composition and a silicone hydrogel substrate having a hydrogel network that allows flow of aqueous solution through the solution and a silicone network that occupies interstices of the hydrogel network. A contact lens having the material enables remote detection of glucose concentration in tear fluid of a subject.

traducir

Página1 de 5 nextPage por página

punteroimgVolver